By Trial: In most cases a single agent is used in a clinical trial but in order to enhance efficacy after data on the single drug is obtained combinations are used in clinical FDA trials to see what advantage can be obtained. As such we saw CMF in breast cancer, FOLFOX in colon cancer and FOLFIERI in pancreatic cancer. Now Abraxane has been added to Gemzar (gemcitabine) for pancreas Ca.
Answered 6/25/2014
4.1k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question